Objective.
We sought to determine changes in the prevalence of comorbid disease following bariatric surgery in Medicaid patients compared to commercially insured patients.
Methods.
Data were obtained from the Longitudinal Assessment of Bariatric Surgery, an observational cohort study of adults undergoing bariatric surgery at one of 6 geographically diverse centers in the US. We identified 1201 patients who underwent Roux-en-Y Gastric Bypass with 5 years of follow-up. We used Poisson mixed models to estimate relative risks (RR) and compare changes in common comorbidities between insurance groups within 0–1 and 1–5 years post-surgery. Propensity scores were used to achieve balance in the baseline comorbidity burden between Medicaid and Commercial patients.
Results.
In the first year, risk of all six comorbidities decreased substantially over time in both groups, ranging from a 32 to 69% decrease from baseline. After 1-year post-surgery, the risk of disease was stable in both groups (RRs ranged from 1.0 to 1.1). After propensity score weighting, the RRs in the first year were more similar in magnitude while the RRs in the 1–5 year period were unchanged.
Conclusions.
These results suggest that Medicaid patients experience medium-term reduction in comorbid disease after bariatric surgery.